Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin G (IgG) is the most abundant class of antibody in human serum, representing approximately 75% of all serum antibodies. It is a glycoprotein produced by plasma B cells as part of the adaptive immune response and is found in blood, lymph, cerebrospinal fluid, peritoneal fluid, and other body fluids. IgG plays several critical roles in immunity, including pathogen neutralization, opsonization, complement activation, antibody-dependent cellular cytotoxicity, and placental transfer to provide passive immunity to the fetus. Detection of specific IgG antibodies indicates prior exposure/infection or successful vaccination. Measurement of IgG levels can help diagnose immunodeficiencies, chronic infections/autoimmune diseases/allergies, and monitor therapy effectiveness.
Binding to antigens to neutralize pathogens, opsonization, complement activation, ADCC.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin G Antibody (IgG).